| Genetic, clinical, and sociodemographic factors associated with stimulant treatment outcomes in ADHD I Brikell, T Wimberley, C Albiñana, EM Pedersen, BJ Vilhjálmsson, ... American Journal of Psychiatry 178 (9), 854-864, 2021 | 16 | 2021 |
| Copy number variants and polygenic risk scores predict need of care in autism and/or ADHD families S LaBianca, J LaBianca, AK Pagsberg, KD Jakobsen, V Appadurai, A Buil, ... Journal of autism and developmental disorders 51, 276-285, 2021 | 12 | 2021 |
| Brief report: Clusters and trajectories across the autism and/or ADHD spectrum S LaBianca, AK Pagsberg, KD Jakobsen, AB Demur, M Bartalan, ... Journal of Autism and Developmental Disorders 48, 3629-3636, 2018 | 11 | 2018 |
| Familial hemiplegic migraine and recurrent episodes of psychosis: a case report S LaBianca, R Jensen, AMJM van den Maagdenberg, L Baandrup, ... Headache: The Journal of Head and Face Pain 55 (7), 1004-1007, 2015 | 7 | 2015 |
| Interplay of ADHD polygenic liability with birth-related, somatic, and psychosocial factors in ADHD: a nationwide study I Brikell, T Wimberley, C Albiñana, BJ Vilhjálmsson, E Agerbo, ... American Journal of Psychiatry 180 (1), 73-88, 2023 | 5 | 2023 |
| Polygenic profiles define aspects of clinical heterogeneity in ADHD S LaBianca, I Brikell, D Helenius, R Loughnan, J Mefford, CE Palmer, ... MedRxiv, 2021.07. 13.21260299, 2021 | 5 | 2021 |
| SA133GENETIC PREDICTION OF TRANSITION FROM CHILDHOOD AND ADOLESCENT PSYCHIATRIC DISORDER TO SCHIZOPHRENIA S LaBianca, V Appadurai, W Thompson, M Nordentoft, T Werge, A Buil, ... European Neuropsychopharmacology 29, S1262, 2019 | 2 | 2019 |
| PA-FGRS is a novel estimator of pedigree-based genetic liability that complements genotype-based inferences into the genetic architecture of major depressive disorder M Dybdahl Krebs, KL Georgii Hellberg, M Lundberg, V Appadurai, ... medRxiv, 2023.06. 23.23291611, 2023 | 1 | 2023 |
| Polygenic profiles define aspects of clinical heterogeneity in attention deficit hyperactivity disorder S LaBianca, I Brikell, D Helenius, R Loughnan, J Mefford, CE Palmer, ... Nature Genetics 56 (2), 234-244, 2024 | | 2024 |
| 34. MULTIPLE POLYGENIC SCORES AND INDIVIDUAL GENOMIC LOCI ASSOCIATE WITH SELF-REPORTED ANTIPSYCHOTIC USE, TREATMENT CESSATION, AND TREATMENT RESISTANCE IN AFFECTIVE DISORDERS KLG Hellberg, Y Jiang, A Forsingdal, S LaBianca, D Dhamija, DA Hinds, ... European Neuropsychopharmacology 75, S75, 2023 | | 2023 |
| PA-FGRS is a novel estimator of pedigree-based genetic liability that complements genotype-based inferences into the genetic architecture of major depressive disorder M Lundberg, V Appadurai, H Ohlsson, EM Pedersen, J Steinbach, ... | | 2023 |
| TH5. ASSOCIATIONS AND INTERACTIONS OF ADHD POLYGENIC LIABILITY WITH PRE-AND PERINATAL, SOMATIC, AND PSYCHOSOCIAL RISK-FACTORS IN THE DEVELOPMENT OF ADHD-A NATIONWIDE STUDY I Brikell, MT Wimberley, C Albiñana, B Vilhjalmsson, E Agerbo, A Børglum, ... European Neuropsychopharmacology 51, e196, 2021 | | 2021 |
| Polygenic profiles define aspects of clinical heterogeneity in ADHD A Schork, S LaBianca, I Brickell, D Helenius, R Loughnan, J Mefford, ... | | 2021 |
| S3ADHD DIAGNOSTIC & GENETIC HETEROGENEITY IN THE IPSYCH CASE-COHORT STUDY S LaBianca, I Brikell, D Helenius, A Schork, S Dalsgaard, T Werge European Neuropsychopharmacology 29, S115, 2019 | | 2019 |
| THE IMPACT OF CNVs ON ASD/ADHD RISK IN MULTIPLEX FAMILIES S LaBianca, M Bartalan, J LaBianca, T Werge European Neuropsychopharmacology 29, S895, 2019 | | 2019 |
